Unitree Technology’s planned listing on China’s Science and Technology Innovation Board is testing how far public-market demand for humanoid robotics can outrun the sector’s current commercial footprint. The company set an issue price of 150.80 yuan per share on Aug. 6, valuing the business at 60.993 billion yuan and assigning it an issue price-to-earnings ratio of 219.23 times, according to its offering materials.
That valuation stands far above the recent one-month average static price-to-earnings ratio of about 38.56 times for China’s general equipment manufacturing industry, as calculated from sector data cited in Unitree’s disclosure. Unitree’s multiple is roughly 5.7 times the industry benchmark, placing a substantial part of the IPO case on expectations that humanoid robots will move from laboratories, exhibitions and pilot deployments into repeatable commercial use.
Retail demand has reinforced the scarcity narrative around the offering. Unitree said its Aug. 10 online subscription attracted 9.78 million retail accounts, producing a preliminary valid subscription multiple of 8,288.82 times. The company described the resulting allocation rate as a record low for the board, leaving most participants without shares in the initial offering.
Research and display remain the main revenue sources
The company’s own filings show that revenue from practical industrial deployment remains limited relative to its public profile in robotics. During the first nine months of 2025, research and education generated 73.6% of Unitree’s humanoid-robot revenue, while commercial displays and performances accounted for a further 17.4%.
Industry applications represented 9.01% of humanoid-robot revenue over the same period, according to the filing. Within that category, manufacturing, inspection and logistics work generated less than 3% of total humanoid-robot revenue, or 15.70 million yuan during the first nine months of 2025.
The distinction matters for a company being valued as a potential industrial-automation leader. Research institutions and education buyers can support early sales, while promotional events demonstrate a robot’s mobility and visual appeal. Neither category necessarily establishes that a robot can perform reliably enough, cheaply enough and safely enough for repeated use on factory floors or in logistics networks.
Unitree’s filing further indicates that corporate guide and reception roles made up the larger share of its industry-application category. The 15.702 million yuan linked to manufacturing, inspection and logistics represented 29.29% of industry-application revenue, with most of the remainder tied to corporate tours and reception deployments.
That breakdown places the company’s near-term business closer to early-stage hardware adoption than to broad replacement of human labor in industrial settings. It also leaves Unitree exposed to a difficult commercial transition: turning high-profile demonstrations and research purchases into recurring orders from companies that can measure a direct operational return.
Growth slowed as research spending increased
Unitree’s latest first-quarter financial figures show rapid revenue growth continuing, though at a slower pace than a year earlier. Revenue reached 423 million yuan, up 68.49% year on year, compared with 332.64% growth in the first quarter of 2025, according to the company’s disclosures.
Net profit excluding non-recurring items fell 52.55% to 40.2536 million yuan from 84.8365 million yuan a year earlier. Unitree attributed the decline partly to higher expenditure on research and development, including a 38.328 million yuan increase in R&D expenses for embodied-intelligence large models, motion-control algorithms and body-structure development. Sales expenses also rose as the company spent more on brand promotion.
The figures show the tension behind the IPO valuation. Unitree is profitable based on the financial numbers it disclosed, but sustaining a technological lead in humanoid robotics requires heavy spending before large industrial orders have arrived. Higher research costs may be necessary to improve a robot’s autonomy and dexterity, yet they also reduce the earnings base used to support a valuation already far above conventional manufacturing peers.
Unitree’s revised risk disclosures reflect that pressure. Between a March draft filing and a May version submitted for listing review, the company added a warning that net profit could decline year on year. The updated materials also identified intensifying competition, including Tesla’s Optimus program, which Unitree said had begun small-batch trial production of its Gen-3 model and had outlined plans for annual capacity of 1 million units.
Industrial orders remain largely experimental
Independent estimates point to a similar gap between robot shipments and industrial adoption. SemiAnalysis estimated that about 250 Unitree robots were used in industrialized scenarios in 2025, compared with total shipments exceeding 5,500 units that year.
Wang Feili, an industrial analyst at UBS Securities China, said that even where manufacturers are targeting output of 10,000 robots this year, most sector orders remain validation purchases rather than expansion orders driven by production demand. Validation purchases allow companies to test a robot’s capabilities, maintenance needs and safety performance, but they do not carry the same revenue visibility as deployments across multiple facilities.
Zhuo Wang, a partner at a Shanghai-based investment institution, told Reuters that the IPO pricing was expensive given that much of Unitree’s revenue still came from research and display applications. Shenwan Hongyuan Research said the elevated issue valuation could draw attention to the commercial value of the humanoid-robot sector and influence how related companies are priced.
Unitree’s Aug. 20 trading debut will therefore be watched less as a simple listing event than as an early market judgment on whether a profitable but still developing robotics business deserves software-like growth expectations. Its financial disclosures suggest the company has built meaningful demand and maintained revenue growth; its revenue mix shows that the industrial market needed to justify its valuation remains at an early stage.
Explore how tokenized equities work and compare crypto market pricing dynamics with high-valuation robotics IPOs like Unitree’s.
Disclaimer: The content on this page is provided for general informational purposes only and does not represent the views or financial advice of Toobit. We make no guarantees regarding the accuracy or completeness of this information and shall not be held liable for any errors, omissions, or outcomes resulting from its use. Investing in digital assets involves risk; users should independently evaluate their financial situation and the risks involved. For further details, please consult our Terms of Service and Risk Disclosure.
